Affymax, Inc.(NASDAQ:AFFY) shares gained 2.84% to $1.46. In its Form 10-Q filed with the SEC, Affymax on May 9 said it has experienced significant operating losses since inception.

Northern, WI 05/10/2013 (GDPInsider) - DURECT Corporation (NASDAQ:DRRX) opened the day's trading at 0.96 and headed south, presently trading at down 40.88%.

XenoPort, Inc. (NASDAQ:XNPT) shares declined 13.48% to $5.84. The company on May 20 announced top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil (AP) for the treatment of patients with spasticity due to multiple sclerosis ...

Affymax, Inc.(NASDAQ:AFFY) shares dropped 4.20% to $1.37. In its Form 10-Q filed with the SEC, Affymax on May 9 said it has experienced significant operating losses since inception.

New York, NY -- (SBWIRE) -- 05/08/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Affymax, Inc. (NASDAQ:AFFY), and ICU Medical, Inc. (NASDAQ:ICUI).

Affymax, Inc. (NASDAQ:AFFY) a biopharmaceutical company that engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses is currently down (-23 ...

Pain Therapeutics, Inc. (NASDAQ:PTIE) stock plunged 49.62% to $2.68. The company on May 10 announced that it received correspondence from Pfizer, Inc. (NYSE:PFE). The company furnished the correspondence with the Securities and Exchange ...

Affymax, Inc. (NASDAQ:AFFY) a biopharmaceutical company that engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses closed down in its ...

Boston, MA 05/20/2013 (wallstreetpr) - The share prices of Affymax Inc. (NASDAQ:AFFY) currently trading at $1.25, down by 6.02%.

New York, NY - (NISMAGAZINE) - 5/14/2013- Affymax, Inc. (NASDAQ:AFFY) opened up from its previous close of $1.31 by $0.07 and now trading at $1.39.